Anna Carter
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 13
- Multiple Myeloma Research and Treatments 9
- Acute Myeloid Leukemia Research 4
- Hematopoietic Stem Cell Transplantation 2
- Oncology 6
- Cancer Treatment and Pharmacology 3
- Co-authors
- I. Tatarsky (10 shared papers)Mariusz Z. Ratajczak (3 shared papers)Janina Ratajczak (3 shared papers)Irit Hocherman (2 shared papers)Jake P. Mann (1 shared paper)Jiali Gao (1 shared paper)Marcin Majka (2 shared papers)Yoram Cohen (1 shared paper)
- Journals
- British Journal of Haematology (5 papers)Cancer (2 papers)Acta Haematologica (1 paper)Journal of Immunological Methods (1 paper)Oncology (1 paper)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Anna Carter
24 papers receiving 404 citations
Peers
Comparison fields: 5 of 63
- Hematology 203
- Genetics 97
- Oncology 90
- Hepatology 19
- Emergency Medicine 21
Countries citing papers authored by Anna Carter
This map shows the geographic impact of Anna Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Carter more than expected).
Fields of papers citing papers by Anna Carter
This network shows the impact of papers produced by Anna Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Carter. The network helps show where Anna Carter may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Carter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 77 | |
| 2 | 1987 | 62 | |
| 3 | 2018 | 53 | |
| 4 | 1980 | 42 | |
| 5 | 1997 | 30 | |
| 6 | Expression, regulation and function of AC133, a putative cell surface marker of primitive human haematopoietic cells. | 2000 | 28 |
| 7 | 1996 | 18 | |
| 8 | 1992 | 18 | |
| 9 | 1984 | 13 | |
| 10 | 1996 | 13 | |
| 11 | 1986 | 9 | |
| 12 | 1985 | 8 | |
| 13 | 1988 | 7 | |
| 14 | 2022 | 6 | |
| 15 | 2021 | 6 | |
| 16 | 1987 | 6 | |
| 17 | 1985 | 5 | |
| 18 | 2017 | 5 | |
| 19 | 2020 | 4 | |
| 20 | 1994 | 3 |
About Anna Carter
Anna Carter is a scholar working on Hematology, Oncology, Immunology, Genetics and Molecular Biology, having authored 24 papers that have together received 421 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (9 papers), Acute Myeloid Leukemia Research (4 papers), Cancer Treatment and Pharmacology (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), HIV/AIDS Research and Interventions (2 papers), Immune Cell Function and Interaction (2 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers). The work is most often cited by research in Hematology (203 citations), Genetics (97 citations), Oncology (90 citations), Hepatology (19 citations) and Emergency Medicine (21 citations). Anna Carter has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include I. Tatarsky, Mariusz Z. Ratajczak, Janina Ratajczak, Irit Hocherman, Jake P. Mann, Jiali Gao, Marcin Majka, Yoram Cohen, Shai Linn and Zbigniew Pietrzkowski. Their work appears in journals such as British Journal of Haematology, Cancer, Acta Haematologica, Journal of Immunological Methods and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.